Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation.
Elizabeth J. Shpall(Scripps MD Anderson Cancer Center), W. P. Peters(Duke University), Robert C. Bast(The University of Texas MD Anderson Cancer Center), S. Eggleston(Duke University), I. C. Anderson(Duke University), Sharon E. Edwards(Duke University), William T. Joines(Duke University), Roy B. Jones(The University of Texas MD Anderson Cancer Center), C. Johnston(Duke University), M. Tepperberg(Duke University)
PubMed
February 1, 1991
Cited by 56
Related Papers
Reactivity of a monoclonal antibody with human ovarian carcinoma.
|Journal of Clinical Investigation|1981|1.7k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
|Clinical Chemistry|2008|1.1k
The measured electrical properties of normal and malignant human tissues from 50 to 900 MHz
|Medical Physics|1994|753